Optimal Sleep Duration Linked to Lower Dementia Risk in Focal Epilepsy

Sleep as a Modifiable Driver of Neurodegeneration in Focal Epilepsy

Focal epilepsy is defined clinically by an enduring predisposition to generate seizures, a condition that necessitates the long-term management of both ictus frequency and complex comorbidities [1]. Beyond the immediate challenges of seizure suppression, clinicians must increasingly address the long-term neurodegenerative risks associated with chronic brain insults, including the accumulation of proteinopathies and vascular injury [2, 3]. Cognitive impairment and dementia represent significant burdens in aging populations, with various factors such as systemic vascular health and sleep quality influencing the overall rate of brain aging [4, 5]. While the relationship between sleep disruption and neurodegeneration is well-established in the general population, its specific role in the cognitive trajectory of patients with focal epilepsy has remained a subject of intense clinical investigation [6]. A new study now examines how sleep duration specifically modifies the risk of dementia in this vulnerable group.

Large-Scale Longitudinal Analysis of Sleep and Cognition

To investigate the intersection of sleep architecture and neurocognitive outcomes, the researchers conducted a large-scale analysis of the prospective UK Biobank cohort, a massive biomedical database containing in-depth genetic and health information. This longitudinal study utilized baseline assessments collected between 2006 and 2010, with a comprehensive follow-up period extending until 2021. The total sample size comprised 482,207 participants who were free of dementia at the time of enrollment. The cohort represented a middle-aged to elderly demographic, with participants aged between 38 and 72 years (mean age 57.6 years; standard deviation 8.1 years; 53.8% female). This robust sample size provides significant statistical power to detect subtle differences in cognitive decline across different neurological conditions.

The study design employed a comparative framework by categorizing participants into three mutually exclusive groups: individuals with focal epilepsy, those with a history of stroke, and healthy controls. This structure allowed the authors to isolate the specific impact of sleep on focal epilepsy relative to another major neurological condition and a baseline healthy population. Beyond the primary cohort, the researchers utilized a nested imaging subsample of 42,345 participants to evaluate structural brain metrics. This subgroup provided the data necessary to correlate self-reported sleep patterns with objective measures of brain total hippocampal and gray matter volumes using generalized linear modeling (a statistical method used to find relationships between variables when the data does not follow a perfectly normal distribution, such as skewed clinical measurements).

Defining Sleep Parameters and Cognitive Outcomes

To quantify the impact of rest on neurological health, the researchers established a clear definition for optimal sleep duration as 6 to 8 hours per night. Participants provided detailed self-reports covering a broad spectrum of sleep characteristics, including the presence of obstructive sleep apnea (a condition where breathing repeatedly stops and starts during sleep), insomnia (persistent difficulty falling or staying asleep), and patterns of daytime napping or dozing. By tracking these specific variables, the study aimed to differentiate between the effects of simple sleep duration and more complex sleep disorders on long-term brain health, providing clinicians with a clearer picture of which sleep behaviors most strongly correlate with cognitive decline.

The primary outcomes of the study were the risk of incident all-cause dementia and Alzheimer disease, which the authors analyzed using Cox proportional hazard modeling. This statistical technique allows clinicians to estimate the risk of a specific event occurring over time, accounting for the duration of the follow-up period. By applying this model to the UK Biobank cohort, the researchers could determine how nonoptimal sleep patterns influenced the hazard ratio (a measure of how often a particular event happens in one group compared to another over time) for developing neurodegenerative conditions over the decade-long study period.

Beyond the primary diagnosis of dementia, the study evaluated secondary outcomes related to cognitive and structural brain integrity. These measures included executive function, which encompasses the mental skills required for planning, focus, and multitasking. Furthermore, the researchers utilized the imaging subsample to measure brain total hippocampal and gray matter volumes. The hippocampus is a critical region for memory formation and is often one of the first areas to show atrophy in Alzheimer disease, while gray matter volume serves as a general marker for neuronal density. By correlating these structural metrics with sleep data, the study provided a biological context for the observed cognitive decline in patients with focal epilepsy.

Executive Function and the Epilepsy-Sleep Interaction

The researchers observed that optimal sleep duration (6 to 8 hours) was associated with better executive function across all three study cohorts, including healthy controls, patients with focal epilepsy, and those in the stroke group. Executive function, which encompasses the cognitive processes necessary for goal-directed behavior such as working memory and cognitive flexibility, appears to be universally sensitive to sleep hygiene. However, the magnitude of this benefit was not uniform across the different patient populations. The study found that the impact of optimal sleep on executive function was significantly higher in individuals with focal epilepsy compared with healthy controls, a finding supported by a significant interaction term (p = 0.009). This suggests that patients with focal epilepsy may have a heightened vulnerability to sleep duration, where adhering to the 6 to 8 hour window provides a more pronounced cognitive benefit than it does for the general population.

In contrast, the relationship between sleep and cognition in the stroke group did not mirror the findings seen in the epilepsy cohort. The impact of optimal sleep on executive function in stroke patients was not significantly different from that observed in the control group (interaction term p = 0.574). This distinction highlights a unique interaction between sleep architecture and the pathophysiology of focal epilepsy that may not be present in other forms of acquired brain injury. Furthermore, the data suggests that sleep disturbances may serve as an early marker of neurological dysfunction. The researchers noted that nonoptimal sleep was associated with worse executive function up to 8 years before the clinical diagnosis of focal epilepsy. This longitudinal association indicates that sleep duration is not merely a comorbid symptom of established epilepsy but may be a long-term correlate of the underlying cognitive decline that precedes formal diagnosis.

Quantifying the Five-Fold Risk of Incident Dementia

The longitudinal analysis of the UK Biobank cohort revealed a stark escalation in long-term neurodegenerative risk for patients with focal epilepsy who do not maintain optimal sleep hygiene. Specifically, the researchers found that individuals with focal epilepsy and nonoptimal sleep had a 5-fold increased risk of developing dementia (hazard ratio [HR] 5.15, 95% CI 3.77-7.04, p < 0.001) when compared with healthy controls who maintained optimal sleep durations of six to eight hours. This risk profile was notably more severe than that observed in other neurological conditions. For instance, stroke individuals with poor sleep had a lower risk of dementia (HR 3.48, 95% CI 2.82-4.26, p < 0.001) than the focal epilepsy group with nonoptimal sleep. These findings suggest that the synergistic effect of epilepsy and sleep disruption creates a particularly potent environment for cognitive decline, exceeding the risk associated with post-stroke sleep disturbances.

The study further investigated how sleep duration functions as a modifier of dementia risk, finding that the protective benefits of optimal sleep were disproportionately high for the epilepsy population. Optimal sleep modified dementia risk in focal epilepsy with a significantly greater improvement compared with healthy controls, as indicated by a significant interaction term (p = 0.017). An interaction term is a statistical measure used to determine if the effect of one variable, such as sleep, differs depending on the presence of another condition, such as epilepsy. In contrast, no significant difference in dementia risk modification by sleep was seen in the stroke group (interaction term p = 0.991). For clinicians, these data emphasize that while sleep hygiene is universally beneficial, it represents a critical, high-yield intervention specifically for patients with focal epilepsy to potentially mitigate their elevated risk of incident dementia and Alzheimer disease.

References

1. Fisher RS, Acevedo CA, Arzimanoglou A, et al. ILAE Official Report: A practical clinical definition of epilepsy. Epilepsia. 2014. doi:10.1111/epi.12550

2. Hyman BT, Phelps CH, Beach TG, et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimer s & Dementia. 2012. doi:10.1016/j.jalz.2011.10.007

3. Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019. doi:10.1093/brain/awz099

4. Wrigglesworth J, Ward PGD, Harding IH, et al. Factors associated with brain ageing - a systematic review. BMC Neurology. 2021. doi:10.1186/s12883-021-02331-4

5. Li Y, Liu Y, Liu S, et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduction and Targeted Therapy. 2023. doi:10.1038/s41392-023-01400-z

6. Carabin H, Ndimubanzi PC, Budke CM, et al. Clinical Manifestations Associated with Neurocysticercosis: A Systematic Review. PLoS neglected tropical diseases. 2011. doi:10.1371/journal.pntd.0001152